Kristin Abate
Chief Accounting Officer at Karyopharm Therapeutics Inc. (KPTI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $10K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 37823,404 held (−2%) | $1.19 | $450 | -49.2% |
| Sep 2SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 1923,782 held (−0%) | $2.02 | $38 | -70.0% |
| May 15SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 5323,801 held (−0%) | $9.50 | $504 | -93.6% |
| Mar 3SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 55922,063 held (−2%) | $9.41 | $5K | -93.6% |
| Jan 29SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 5022,622 held (−0%) | $7.03 | $352 | -91.4% |
| Jan 22SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 26522,580 held (−1%) | $5.96 | $2K | -89.8% |
| Oct 3SEC | KPTIKaryopharm Therapeutics Inc. | Sell | 36210,046 held (−3%) | $6.30 | $2K | -90.4% |